Precision Antibody’s CEO to Speak at 23rd BioPharma Drug Discovery Nexus in San Francisco


Posted May 5, 2025 by precisionantibody

Precision Antibody CEO Dr. Ginette Serrero to speak at the 23rd BioPharma Drug Discovery Nexus, May 7–8 in San Francisco, on advancing monoclonal antibody development for early-stage drug discovery.

 
Columbia, MD—May 5, 2025—Precision Antibody, a trusted leader in the development of custom monoclonal antibodies, proudly announces that its CEO, Dr. Ginette Serrero, will speak at the upcoming 23rd BioPharma Drug Discovery Nexus, taking place May 7–8, 2025, at Embassy Suites by Hilton in San Francisco, California.
The BioPharma Drug Discovery Nexus (DDN) is an international forum that brings together top experts, researchers, and innovators in drug discovery and development. The event explores the latest technologies and strategies driving breakthroughs in early-stage drug development, translational science, and biologics.
Dr. Lin will speak on the importance of producing high-affinity, high-specificity monoclonal antibodies in early-stage drug discovery and how Precision Antibody’s proven processes help researchers generate reliable data—fast.
“Our commitment is to help researchers accelerate discovery by providing antibodies that work right the first time,” said Dr. Serrero. “I look forward to joining fellow thought leaders at BioPharma Drug Discovery Nexus to share best practices and forward-looking perspectives on antibody development.”
Dr. Serrero’s decades of experience in monoclonal antibody production and Precision Antibody’s track record of speed and success position the company as a key enabler of translational and therapeutic discovery programs in academia and industry.
About Precision Antibody
The company has more than two decades of experience providing personalized services for monoclonal and polyclonal antibody development. Founded in 2000, it is now a global leader in delivering solutions for therapeutic and research purposes. It is also equipped to tackle antibody requirements for oncology, immunology, and regenerative medicine. The company deals with academic research centers and worldwide pharma companies.

Media Contact:
Precision Antibody
Dr. Jun Hayashi
President
Phone: 410-884-4100
Email: [email protected]
Website: www.precisionantibody.com

Event Details:
BioPharma Drug Discovery Nexus (DDN US)
Dates: May 7 - 8, 2025
Venue: Embassy Suites by Hilton in San Francisco, CA
Event Website: https://nexus-conference.com/ddnus/
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Precision Antibody
Phone 410-884-4100
Business Address 9130 Red Branch Road, Suite X, Columbia, MD 21045
Country United States
Categories Medical
Tags antibody , antibody development , antibody production , precision antibody , drug discovery
Last Updated May 5, 2025